Use of ABC typing to redefine subtypes of acute-onset type 1 diabetes mellitus: Study of 308 patients

National Medical Journal of China

Volumn 88, Issue 12, 2008, Pages 797-801

  Zhang, Chi ^a   Zhou, Zhi Guang ^a   Lin, Jian ^a   Huang, Gan ^a   Wang, Jian Ping ^a   Zhang, Dong Mei ^a   Zhou, Min ^a   Yang, Xiao Lin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Autoantibodies; Body mass index; Diabetes mellitus, type 1

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA ANTIGEN; HLA DQ ANTIGEN; INSULIN; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CELL FUNCTION; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DIET RESTRICTION; DISEASE CLASSIFICATION; DOSE RESPONSE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; OBESITY; PANCREAS ISLET BETA CELL; PHARMACOGENETICS; POSTPRANDIAL STATE; PROGNOSIS; PROTEIN BLOOD LEVEL; RADIOASSAY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; VENOUS BLOOD;

ACUTE DISEASE; ADOLESCENT; ADULT; AUTOANTIBODIES; C-PEPTIDE; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; GLUTAMATE DECARBOXYLASE; HLA-DQ ANTIGENS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN TYROSINE PHOSPHATASES; RADIOLIGAND ASSAY; YOUNG ADULT;

EID: 44449102210     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999.
2. Kitabchi AE, Umpierrez GE, Murphy MB, et al. American Diabetes Association. Hyperglycemic crises in diabetes. Diabetes Care. 2004, 27 Suppl 1: S94-102.
3. Chinese source.
4. Chinese source.
5. Siraj ES, Reddy SS, Scherbaum WA, et al. Basal and postglucagon C-peptide levels in Ethiopians with diabetes. Diabetes Care, 2002,25:453-457.
6. Palmer JP, Fleming GA, Greenbaum CJ, et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes, 2004,53:250-264.
7. Chinese source.
8. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet, 2001,358: 221-229.
9. Greenbaum CJ. Insulin resistance in type 1 diabetes. Diabetes Metab Res Rev, 2002,18:192-200.
10. Gillespie KM, Bain SC, Barnett AH, et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet, 2004,364:1699-1700.
11. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia. 2001,44: 914-922.
12. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care, 2004,27:813-823.
13. Weets I, Siraux V, Daubresse JC, et al. Relation between disease phenotype and HLA-DQ genotype in diabetic patients diagnosed in early adulthood. J Clin Endocrinol Metab, 2002,87:2597-2605.